Picture of Benitec Biopharma logo

BNTC Benitec Biopharma Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual cashflow statement for Benitec Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARS10-K10-K10-K10-K
Standards:
IFRS
USG
USG
USG
USG
Status:
fx
Final
FinalFinalFinalFinal
Changes in Working Capital4.19-7.54-12.8-15.9-18
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities4.19-7.54-12.8-15.9-18
Capital Expenditures-0.412-0.095-0.221-0.013-0.001
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0040.0010
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-0.408-0.094-0.221-0.013-0.001
Financing Cash Flow Items0-0.48-3.230-1.87
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities01.7722.5016
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4.52-5.929.97-15.7-1.59